Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patie...
Saved in:
Main Authors: | Christie Walker (Author), Shawky Z. A. Badawy (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022) -
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
by: Lam C, et al.
Published: (2016) -
Effect of depot-medroxyprogesterone acetate injections on serum immunoglobulins and complements level
by: Wahda B. Al-Youzbaki
Published: (2008) -
The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive
by: Robyn Schickler, et al.
Published: (2021) -
The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions
by: Baharuddin Aras, et al.
Published: (2018)